GL1X · GenesisL1 explorer

MolNFT v2 · #124062 · protein

5JSN: Bcl2-inhibitor complex

5JSN · Apoptosis regulator Bcl-2: “Bcl2-inhibitor complex”. X-ray diffraction at 2.1, 8 pockets (best druggability 0.59). MolNFT v2 #124062 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

3D structure of 5JSN: Bcl2-inhibitor complex (MolNFT v2 / PDB Bank)
3D structure of 5JSN: Bcl2-inhibitor complex (MolNFT v2 / PDB Bank)
PDB
5JSN
Type
protein
Length
528 residues
Chains
4
Method
x-ray diffraction
Authors
Shen, B.W., Stoddard, B.L.
Deposited
05/09/16
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.1
Source
Homo sapiens; unidentified
Molecule
Apoptosis regulator Bcl-2; Bcl2 inhibitor
UniProt
P10415
Pockets
8 · best druggability 0.59

Structure

x-ray diffraction · resolution 2.1 · 2 distinct chains · 80% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CApoptosis regulator Bcl-2protein14973% helix, 0% strandP10415
B, DBcl2 inhibitorprotein11589% helix, 0% strand—

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1590.590.9017empty
2520.580.9119empty
31480.460.7621empty
4810.360.7615empty
5510.360.7912empty

Interfaces

3 interfaces between chains.

  • A–B · 1602 Ų buried · 23 hydrogen bonds · protein-protein
  • C–D · 1513 Ų buried · 26 hydrogen bonds · protein-protein
  • B–D · 439 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 5JSN · BCL2-inhibitor complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P10415 · AlphaFold monomer V2.0 prediction for apoptosis regulator BCL-2 (P10415) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

Other records of 5JSN

  • 5JSN-2 · MolNFT v1 / PDB · BCL2-inhibitor complex

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.